Durable response using regorafenib in an elderly patient with metastatic colorectal cancer: case report
Ronald Tang,1 Tatiana Kain,2 June Herman,2 Tara Seery1 1Division of Hematology-Oncology, 2Division of Nuclear Medicine and Molecular Imaging, University of California, Irvine, Orange, CA, USA Abstract: Regorafenib, an oral multikinase inhibitor, was approved in September 2012 by the US Food and Dru...
| 出版年: | Cancer Management and Research |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Dove Medical Press
2015-11-01
|
| オンライン･アクセス: | https://www.dovepress.com/durable-response-using-regorafenib-in-an-elderly-patient-with-metastat-peer-reviewed-article-CMAR |